The Role of Patient-Reported Outcomes and Patient Preference Information in Regulatory and HTA Decision Making
Moderator
Tamas Agh, MSc, PhD, MD, Center for HTA and Pharmacoeconomic Research, University of Pecs & Syreon Research Institute, Budapest, Hungary
Patient-reported outcomes (PROs) and patient preference information (PPI) are increasingly considered by regulatory and HTA bodies. This session will examine the role of PROs and PPI in regulatory approvals and HTA decision-making, highlighting current trends, key challenges, and opportunities to enhance patient-centered decision-making.
Code
025